Long-lasting Hypotensive Effect in Renal Hypertensive Rats Induced by Nitric Oxide Released From a Ruthenium Complex


Autoria(s): Rodrigues, Gerson J.; Pereira, Amanda C.; Vercesi, Juliana A.; Lima, Renata G.; Silva, Roberto S.; Bendhack, Lusiane M.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

In this study, we investigated the effect of the ruthenium complex [Ru(terpy)(bdq)NO+](3+) (TERPY) on the arterial pressure from renal hypertensive 2 kidney-1 clip (2K-1C) rats, which was compared with sodium nitroprusside (SNP). The most interesting finding was that the intravenous bolus injection of TERPY (2.5, 5.0, 7 mg/kg) had a dose-dependent hypotensive effect only in 2K-1C rats. On the other hand, SNP (35 and 70 mu g/kg) presented a similar hypotensive effect in both normotensive (2K) and 2K-1C although the effect of 70 mu g/kg was >35 mu g/kg. The injection of the nonselective NO-synthase inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME) increased the arterial pressure in 2K and 2K-1C rats with a similar magnitude. After infusion of L-NAME, the hypotensive effect induced by TERPY and SNP was potentiated in both 2K and in 2K-1C rats. The administration of the superoxide scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl increased the hypotensive effect induced by TERPY or SNP in both 2K and 2K-1C rats. The hypotensive effect induced by TERPY was longer than that produced by SNP. Taken together, our results show that the TERPY has a long-lasting hypotensive effect, which has a dose dependence and higher magnitude in 2K-1C compared with in 2K rats. In comparison with SNP, TERPY is less potent in inducing arterial pressure fall, but it presents a much longer hypotensive effect.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Identificador

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, PHILADELPHIA, v. 60, n. 2, supl. 1, Part 1, pp. 193-198, AUG, 2012

0160-2446

http://www.producao.usp.br/handle/BDPI/41888

10.1097/FJC.0b013e31825bacc4

http://dx.doi.org/10.1097/FJC.0b013e31825bacc4

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

PHILADELPHIA

Relação

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Direitos

closedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #NITRIC OXIDE DONOR #RENAL HYPERTENSION #HYPOTENSIVE EFFECT #SUPEROXIDE SCAVENGER #NO SYNTHASE #VISIBLE-LIGHT IRRADIATION #VASCULAR SMOOTH-MUSCLE #SODIUM-NITROPRUSSIDE #NITRATE TOLERANCE #AORTA RELAXATION #SUPEROXIDE ANION #NO-DONOR #NITROVASODILATORS #ENDOTHELIUM #DYSFUNCTION #CARDIAC & CARDIOVASCULAR SYSTEMS #PHARMACOLOGY & PHARMACY
Tipo

article

original article

publishedVersion